end of life care - Nursing Case Study

Pathophysiology

• Primary mechanism: Organ Failure - As the body nears end of life, vital organs such as the heart, lungs, and kidneys often begin to fail due to chronic disease progression or acute exacerbation. This results in decreased physiological function and systemic instability, requiring supportive care to manage symptoms and maintain comfort.

• Secondary mechanism: Metabolic Imbalance - Dying patients frequently experience metabolic disturbances, including electrolyte imbalances and acid-base disorders, due to the body's impaired ability to maintain homeostasis. These imbalances can exacerbate organ dysfunction and contribute to the patient's overall decline.

• Key complication: Pain and Symptom Management - Effective end of life care focuses on alleviating pain and other distressing symptoms (e.g., dyspnea, agitation) arising from organ failure and metabolic imbalances, thereby improving the quality of life in the patient's final days.

Patient Profile

Demographics:

67-year-old female, retired school teacher

History:

• Key past medical history: Stage IV lung cancer, COPD, hypertension

• Current medications: Morphine, lorazepam, lisinopril, albuterol inhaler

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing shortness of breath and chest pain

• Key symptoms: Persistent cough, fatigue, weight loss, difficulty swallowing

• Vital signs: Temperature 99.1°F, Heart rate 112 bpm, Respiratory rate 28 breaths per minute, Blood pressure 88/56 mmHg, Oxygen saturation 82% on room air

Section 1

As the healthcare team proceeds with the initial assessment, they note several critical findings. The patient is visibly distressed, with labored breathing and using accessory muscles for respiration. Her skin appears pale and diaphoretic, and she is experiencing intermittent episodes of confusion. Auscultation of the lungs reveals diminished breath sounds bilaterally with crackles present at the bases, indicative of fluid accumulation. Given her low oxygen saturation of 82% on room air, supplemental oxygen via nasal cannula is initiated, which slightly improves her saturation to 86%. Her heart rate remains elevated at 112 bpm, suggesting tachycardia likely secondary to hypoxemia and possible anxiety or pain.

Blood tests are ordered to further elucidate her condition, and initial results reveal significant metabolic imbalances. The arterial blood gas (ABG) shows a pH of 7.32, indicating acidosis, with a partial pressure of carbon dioxide (PaCO2) at 55 mmHg, suggesting respiratory acidosis. Additionally, her bicarbonate (HCO3-) level is 18 mEq/L, pointing to a concurrent metabolic acidosis. This dual acid-base disturbance highlights the body's struggle to compensate for respiratory failure and possible renal insufficiency. Electrolyte analysis shows hyponatremia and hyperkalemia, both of which can exacerbate her cardiovascular instability and contribute to her confusion.

In response to these findings, the healthcare team prioritizes interventions to address her dyspnea and electrolyte imbalances while ensuring comfort. Morphine is administered to alleviate pain and reduce the sensation of breathlessness, while a nebulized albuterol treatment is given to relieve bronchospasm. The patient's fluid status is closely monitored to prevent fluid overload, which could worsen pulmonary congestion. The team discusses the potential need for a palliative care consultation to ensure comprehensive management of her symptoms and address the evolving needs of both the patient and her family. As her condition remains tenuous, the team is vigilant for any new complications that may arise, poised to adjust the care plan as necessary to maintain her comfort and dignity in her final days.

Section 2

As the healthcare team continues to monitor the patient, they note a change in her clinical status that requires immediate attention. Despite the initial interventions, her respiratory effort becomes more pronounced, with increased use of accessory muscles and audible wheezing indicating exacerbation of her respiratory distress. Her oxygen saturation levels, even with supplemental oxygen, begin to decline gradually to 82%, suggesting that her respiratory function is further compromised. The patient becomes more lethargic, with longer periods of confusion, which raises concerns about inadequate cerebral perfusion and the worsening of acid-base imbalances.

A repeat arterial blood gas (ABG) analysis reveals a further decline in her respiratory status with a pH of 7.28, a PaCO2 of 60 mmHg, and a further decrease in bicarbonate to 16 mEq/L. These findings confirm the progression of her respiratory acidosis coupled with metabolic acidosis, indicating that her body is struggling to compensate. Additionally, her potassium levels have increased slightly to 6.2 mEq/L, which poses a risk for cardiac arrhythmias. Her blood pressure has dropped to 88/54 mmHg, suggesting the onset of hypotension, likely due to a combination of her metabolic derangements and possible dehydration.

Given these developments, the team revises her management plan. They consider the introduction of non-invasive ventilation support to improve her respiratory mechanics and gas exchange. Measures to correct her electrolyte imbalances are intensified, with the cautious administration of intravenous fluids and medications to lower her potassium levels. The team also re-evaluates her pain management plan, ensuring that her comfort remains a priority while balancing the potential for respiratory depression from opioid use. These adjustments aim to stabilize her condition, but the healthcare team remains aware that her prognosis is guarded. The potential need for a more aggressive palliative approach is discussed with her family, emphasizing the importance of aligning her care with her goals and ensuring dignity and comfort during this critical phase.

Section 3

As the healthcare team implements the revised management plan, they closely monitor the patient's response to interventions. The introduction of non-invasive ventilation shows some initial improvement in her respiratory effort, with a slight reduction in the use of accessory muscles. However, the patient's oxygen saturation remains precarious, fluctuating between 85% and 88%, indicating ongoing respiratory compromise. Despite adjustments in her ventilation settings, the patient continues to exhibit periods of confusion and lethargy, suggesting persistent cerebral hypoperfusion and the challenge of balancing sufficient respiratory support with her overall comfort and cognitive clarity.

The patient's latest laboratory results provide further insight into her evolving clinical picture. A repeat arterial blood gas analysis shows a slight improvement in her pH to 7.30, yet her PaCO2 remains elevated at 58 mmHg, and bicarbonate levels remain low at 18 mEq/L. These values suggest a marginal improvement in her acid-base status but highlight the persistent underlying respiratory acidosis. Concurrently, her serum potassium has decreased to 5.8 mEq/L following the cautious administration of medications, reducing the immediate risk of cardiac arrhythmias. However, her blood pressure remains low at 90/56 mmHg, raising concerns about adequate perfusion and the potential need for further fluid resuscitation.

Throughout these developments, the healthcare team remains vigilant for any new complications. They consider the risk of potential aspiration due to her compromised respiratory status and lethargy, as well as the possibility of developing infections given her overall weakened state. As they continue to engage with the patient's family, discussions about the balance between aggressive interventions and palliative measures take on renewed importance. The team emphasizes the need to prioritize the patient's comfort and dignity, ensuring that her care aligns with her values and wishes during this critical phase of her journey.

Section 4

As the healthcare team continues to monitor the patient, new complications begin to emerge, prompting a reassessment of her condition. Overnight, the patient develops a low-grade fever of 37.8°C (100°F), and her white blood cell count rises to 14,000/mm³, indicating a possible infectious process. Given her lethargy and respiratory compromise, the team suspects the development of hospital-acquired pneumonia, a not uncommon complication in patients with compromised respiratory function and prolonged periods of immobility. A chest X-ray is ordered and reveals new infiltrates in the right lower lobe, corroborating the suspicion of pneumonia.

In response to these findings, the healthcare team initiates broad-spectrum antibiotics to address the potential infection, while continuing to support her respiratory status with non-invasive ventilation. They also increase the frequency of her respiratory assessments to monitor for any further deterioration. Meanwhile, the patient's blood pressure remains concerning, with readings consistently around 88/54 mmHg. The team deliberates on whether to initiate low-dose vasopressors to maintain adequate tissue perfusion, weighing the risk of further compromising her respiratory status due to increased cardiac workload.

As the team navigates these challenges, they engage in discussions with the patient's family about the evolving situation. They emphasize the importance of maintaining the patient's comfort and aligning care with her previously expressed wishes. Given the new complication of suspected pneumonia and the patient's overall fragile state, the family is encouraged to consider the balance between continued aggressive treatment and a shift towards a more palliative approach, ensuring that the patient's dignity and quality of life remain central to the care plan. These discussions are crucial as the team prepares to address the next steps in the patient's care, with an understanding that her journey is becoming increasingly complex.

Section 5

As the healthcare team continues to monitor the patient closely, they observe a change in her status that necessitates prompt attention. Despite the initiation of broad-spectrum antibiotics, the patient exhibits increasing respiratory distress. Her oxygen saturation levels have dropped to 88% on non-invasive ventilation at 50% FiO2, and she appears more tachypneic, with a respiratory rate now elevated to 28 breaths per minute. These findings indicate that her respiratory compromise is worsening, prompting the team to reassess her current management plan.

A follow-up arterial blood gas analysis reveals a pH of 7.32, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg, indicating the development of acute respiratory acidosis with hypoxemia. The team recognizes that her respiratory muscles are becoming fatigued, unable to maintain adequate ventilation. Concurrently, her blood pressure remains borderline at 86/52 mmHg, and her heart rate is now 112 beats per minute, suggesting compensatory tachycardia due to persistent hypotension and hypoxia.

In response to these changes, the team convenes to discuss the potential need for escalation to invasive mechanical ventilation, weighing it against the patient’s advance directives and her frail condition. They also consider the judicious use of low-dose vasopressors to support her hemodynamic status, aiming to optimize perfusion without imposing undue stress on her cardiovascular system. These deliberations are shared with the family, ensuring they are informed and involved in the decision-making process, as the team seeks to balance life-sustaining interventions with the overarching goal of honoring the patient's wishes and maintaining her comfort.